CSS LLC’s Xeris Biopharma Holdings XERS Stock Holding History

CSS LLC’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,500	Closed	-$7K	–	1339
2021 Q4	$7K	Buy	+2,500	New	+$5.4K	﹤0.01%	1216

Other funds holding XERS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

CSS LLC's XERS Position: Q2 2024 in Review

CSS LLC sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 18,124 shares — an estimated $40.1K sold.

CSS LLC first reported a position in XERS in Q4 2021 and held it in 9 quarters. The position peaked at $205K in Q4 2021. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

CSS LLC reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
CSS LLC sold 18,124 Xeris Biopharma Holdings shares in Q2 2024, an estimated $40.1K.
CSS LLC first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 9 quarters.
CSS LLC's Xeris Biopharma Holdings position peaked at $205K in Q4 2021.
134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on CSS LLC's 13F filing for Q2 2024, filed 14 Aug 2024.